comparemela.com

Latest Breaking News On - Sparta biopharma inc - Page 1 : comparemela.com

This common shoulder injury could heal faster, thanks to the first implant that recreates a crucial tissue structure

This common shoulder injury could heal faster, thanks to the first implant that recreates a crucial tissue structure
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.

Rush-university
Illinois
United-states
Chicago
Eric-nauman
Dimitrios-angelis
Adam-yanke
Darryl-dickerson
Most-innovative-university
Purdue-university
Purdue-research-foundation-office-of-technology-commercialization
Florida-international-university

Sparta Biomedical Receives FDA Breakthrough Device Designation for SBM-01 Biomimetic Implant

Share this article Share this article DURHAM, N.C., March 17, 2021 /PRNewswire/ Sparta Biomedical Inc., a developer of orthopedic solutions, today announced that its SBM-01 Biomimetic Implant has been granted a Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). SBM-01 is intended to replace damaged knee cartilage in patients having single or multiple chondral or osteochondral defects in the knee. The Breakthrough Device Program is designed to accelerate patient access to promising technologies that have the potential to provide more effective treatments for debilitating conditions. The Program provides patients and health care providers timely access to these medical devices by assisting sponsors in their development, assessment, and review, consistent with the FDA s mission to protect and promote public health.

Dimitrios-angelis
Adam-yanke
Breakthrough-device-program
Prnewswire-sparta-biomedical-inc
Drug-administration
Department-of-orthopedics
Sparta-biopharma-inc
Rush-university-medical-center
Cartilage-restoration-center
Sparta-biomedical-inc
Dushyanth-surakanti-co
Biomedical-inc

Sparta Biopharma Announces US Commercial Availability of BioEnthesis™ for Rotator Cuff Repair

Sparta Biopharma Announces US Commercial Availability of BioEnthesis™ for Rotator Cuff Repair News provided by Share this article Share this article DURHAM, N.C. and MADISON, N.J., March 9, 2021 /PRNewswire/  Sparta Biopharma, Inc., a privately-held company, developing osteobiologics for sports medicine announces the availability of BioEnthesis TM, the first-of-its-kind allograft that has both mineralized and demineralized layers which provide the requisite properties for healing and repair within the rotator cuff.  According to the Healthcare Cost and Utilization Project, there are more than 4.5 million physician visits per year for rotator cuff pain and dysfunction. Osteobiologics have been used successfully over the last several decades. These allografts have facilitated the formation of functional bone tissue and the healing of bone. In that time, hundreds of allograft compositions and forms have served patients across multiple orthopedic ailments. However, their pote

Dimitrios-angelis
Adam-yanke
Dushyanth-surakanti
Sparta-biopharma-inc
Sparta-biopharma
Healthcare-cost
Utilization-project
Scientific-advisory-board
Assistant-professor
Midwest-orthopedics
Good-tissue

vimarsana © 2020. All Rights Reserved.